XML 34 R23.htm IDEA: XBRL DOCUMENT v2.4.0.6
LIQUIDITY AND SIGNIFICANT ACCOUNTING POLICIES: (Details 2) (USD $)
 3 Months Ended 0 Months Ended 3 Months Ended 12 Months Ended 3 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2012
Restricted Stock
Nov. 15, 2012
Restricted Stock
Non-executive directors
Dec. 31, 2012
Stock Options
Sep. 30, 2012
Stock Options
Dec. 31, 2012
Warrants
Consultants
Dec. 31, 2011
Warrants
Consultants
Stock- Based Compensation                
Remaining costs related to non-vested restricted stock awards (in dollars) $ 208,000              
Stock compensation expense 90,000 171,000            
Granted (in shares)       52,500        
Number of Shares                
Outstanding at the beginning of the period (in shares)         1,362,500      
Granted (in shares)         250,000      
Outstanding at the end of the period (in shares)         1,612,500 1,362,500    
Weighted Average Exercise Price                
Outstanding at the beginning of the period (in dollars per share)         $ 1.19      
Granted (in dollars per share)         $ 0.95      
Outstanding at the end of the period (in dollars per share)         $ 1.15 $ 1.19    
Weighted Average Remaining Contractual Term                
Outstanding at the end of the period         8 years 7 months 6 days 8 years 7 months 6 days    
Aggregate Intrinsic Value                
Outstanding at the end of the period (in dollars)         37,500 140,000    
Other disclosures                
Options outstanding that were vested and exercisable (in shares)         412,500      
Additional options outstanding that are expected to vest (in shares)         1,200,000      
Options outstanding (in shares)     52,500          
Remaining costs related to non-vested restricted stock awards (in dollars)     150,000          
Warrant expense recognized (in dollars)   $ 3,000         $ 3,056 $ 9,357